Arkolith/Insider Trading/MGX/Form 4

Wapnick Pamela

Chief Financial OfficerMetagenomi Therapeutics, Inc. (MGX) · full profile →Form 4 · filed Jun 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2026Sell(S)3K$1.30$4K208K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-265335) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML